These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 20881608

  • 1. Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1.
    Tao R, Kim SH, Honbo N, Karliner JS, Alano CC.
    J Cardiovasc Pharmacol; 2010 Dec; 56(6):659-68. PubMed ID: 20881608
    [Abstract] [Full Text] [Related]

  • 2. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.
    Alano CC, Kauppinen TM, Valls AV, Swanson RA.
    Proc Natl Acad Sci U S A; 2006 Jun 20; 103(25):9685-90. PubMed ID: 16769901
    [Abstract] [Full Text] [Related]

  • 3. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ, Bourgeois M, Harbison RD.
    Cardiovasc Toxicol; 2018 Dec 20; 18(6):493-506. PubMed ID: 29968072
    [Abstract] [Full Text] [Related]

  • 4. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S.
    J Pharmacol Exp Ther; 2004 Aug 20; 310(2):425-36. PubMed ID: 15075382
    [Abstract] [Full Text] [Related]

  • 5. BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase.
    Szabados E, Literati-Nagy P, Farkas B, Sumegi B.
    Biochem Pharmacol; 2000 Apr 15; 59(8):937-45. PubMed ID: 10692558
    [Abstract] [Full Text] [Related]

  • 6. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
    Oh KS, Lee S, Yi KY, Seo HW, Koo HN, Lee BH.
    J Pharmacol Exp Ther; 2009 Jan 15; 328(1):10-8. PubMed ID: 18836068
    [Abstract] [Full Text] [Related]

  • 7. Differences among cell types in NAD(+) compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes.
    Alano CC, Tran A, Tao R, Ying W, Karliner JS, Swanson RA.
    J Neurosci Res; 2007 Nov 15; 85(15):3378-85. PubMed ID: 17853438
    [Abstract] [Full Text] [Related]

  • 8. Poly (ADP-ribose) polymerase inhibition protects against myocardial ischaemia/reperfusion injury via suppressing mitophagy.
    Cao S, Sun Y, Wang W, Wang B, Zhang Q, Pan C, Yuan Q, Xu F, Wei S, Chen Y.
    J Cell Mol Med; 2019 Oct 15; 23(10):6897-6906. PubMed ID: 31379115
    [Abstract] [Full Text] [Related]

  • 9. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
    Halmosi R, Berente Z, Osz E, Toth K, Literati-Nagy P, Sumegi B.
    Mol Pharmacol; 2001 Jun 15; 59(6):1497-505. PubMed ID: 11353811
    [Abstract] [Full Text] [Related]

  • 10. Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes.
    Gerö D, Szoleczky P, Chatzianastasiou A, Papapetropoulos A, Szabo C.
    Mol Med; 2014 Jul 31; 20(1):313-28. PubMed ID: 24842055
    [Abstract] [Full Text] [Related]

  • 11. AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy.
    Liu M, Li Z, Chen GW, Li ZM, Wang LP, Ye JT, Luo HB, Liu PQ.
    Mol Cell Endocrinol; 2014 Jul 05; 392(1-2):14-22. PubMed ID: 24859603
    [Abstract] [Full Text] [Related]

  • 12. [Poly (ADP-ribose) polymerase inhibition attenuates ischemia/reperfusion induced myocardial injury in rat via reducing myocardial nuclear factor κB activity].
    Song ZF, DU B, Ji XP.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec 05; 40(12):997-1002. PubMed ID: 23363712
    [Abstract] [Full Text] [Related]

  • 13. Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death.
    Kauppinen TM, Swanson RA.
    J Immunol; 2005 Feb 15; 174(4):2288-96. PubMed ID: 15699164
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of poly(adp-ribose) polymerase reduces cardiomyocytic apoptosis after global cardiac arrest under cardiopulmonary bypass.
    Yeh CH, Chen TP, Lee CH, Wu YC, Lin YM, Jing Lin P.
    Shock; 2006 Feb 15; 25(2):168-75. PubMed ID: 16525356
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of cardioplegia with poly (ADP-ribose) polymerase-1 inhibitor against myocardial ischemia-reperfusion injury: in vitro study of isolated rat heart model.
    Yamazaki K, Tanaka S, Sakata R, Miwa S, Oriyanhan W, Takaba K, Minakata K, Marui A, Ikeda T, Toyokuni S, Komeda M, Ueda K.
    J Enzyme Inhib Med Chem; 2013 Feb 15; 28(1):143-7. PubMed ID: 22168830
    [Abstract] [Full Text] [Related]

  • 16. Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection.
    Skaper SD.
    Ann N Y Acad Sci; 2003 May 15; 993():217-28; discussion 287-8. PubMed ID: 12853316
    [Abstract] [Full Text] [Related]

  • 17. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
    Komjáti K, Besson VC, Szabó C.
    Curr Drug Targets CNS Neurol Disord; 2005 Apr 15; 4(2):179-94. PubMed ID: 15857303
    [Abstract] [Full Text] [Related]

  • 18. Involvement of independent mechanism upon poly(ADP-ribose) polymerase (PARP) activation in methylmercury cytotoxicity in rat cerebellar granule cell culture.
    Sakaue M, Mori N, Okazaki M, Ishii M, Inagaki Y, Iino Y, Miyahara K, Yamamoto M, Kumagai T, Hara S, Yamamoto M, Arishima K.
    J Neurosci Res; 2008 Nov 15; 86(15):3427-34. PubMed ID: 18627028
    [Abstract] [Full Text] [Related]

  • 19. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.
    Pacher P, Szabó C.
    Cardiovasc Drug Rev; 2007 Nov 15; 25(3):235-60. PubMed ID: 17919258
    [Abstract] [Full Text] [Related]

  • 20. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia.
    Suh SW, Aoyama K, Chen Y, Garnier P, Matsumori Y, Gum E, Liu J, Swanson RA.
    J Neurosci; 2003 Nov 19; 23(33):10681-90. PubMed ID: 14627653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.